PPAR alpha, agonists
- Name
- PPAR alpha, agonists
- Accession Number
- DBCAT001673
- Description
Not Available
- Drugs
Drug Drug Description Elafibranor Investigated for use/treatment in atherosclerosis and diabetes mellitus type 2. Muraglitazar Investigated for use/treatment in diabetes mellitus type 2. Lobeglitazone Lobeglitazone was approved by the Ministry of Food and Drug Safety (South Korea) in 2013, and is being monitored by postmarketing surveillance until 2019. Lobeglitazone is not approved for use... Naveglitazar Naveglitazar has been used in trials studying the treatment of Diabetes Mellitus, Non-Insulin-Dependent. - Drugs & Drug Targets